Medical device company, Asensus Surgical, Inc., (NYSE American: ASXC), has received 510(k) clearance from the FDA for an expanded indication to treat pediatric patients with the Senhance® System. Highlights Asensus’ Senhance System combines 3mm instrumentation, 5mm camera scope, haptic feedback, and advanced clinical intelligence provided by the Intelligent Surgical Unit™ to bring the benefits of…
[Read More]